| Brandon Charles Doucette, PHARMD | |
|
800 Islington St Unit 1, Portsmouth, NH 03801-4272 | |
| (603) 436-2214 | |
| Not Available |
| Full Name | Brandon Charles Doucette |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 800 Islington St Unit 1, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366756363 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3714 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brandon Charles Doucette, PHARMD 800 Islington St Unit 1, Portsmouth, NH 03801-4272 Ph: (603) 436-2214 | Brandon Charles Doucette, PHARMD 800 Islington St Unit 1, Portsmouth, NH 03801-4272 Ph: (603) 436-2214 |
News Archive
Omnicare, Inc. today announced that it intends to offer $400 million aggregate principal amount of senior subordinated notes due 2020, pursuant to a preliminary prospectus supplement to be filed with the Securities and Exchange Commission under the Company's shelf registration statement.
Ligand Pharmaceuticals Incorporated announced that results from the Phase II study of its Captisol-enabled, propylene glycol-free (PG-free) Melphalan program were featured this evening in a poster presentation at the combined annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society for Blood and Marrow Transplantation (ASBMT) in San Diego.
It may soon be possible to manage the serious condition of diabetes naturally using nutmeg seeds (Myristica fragrans) according to new research presented today at the British Pharmaceutical Conference in Manchester.
Results from two Phase 1 studies of ZOLINZA (vorinostat), Merck's oral histone deacetylase (HDAC) inhibitor, administered in combination with bortezomib, showed early anti-tumor activity in patients with relapsed and/or refractory multiple myeloma, including those previously treated with and no longer responding to bortezomib.
› Verified 5 days ago
David Cabral, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1390 Lafayette Rd, Portsmouth, NH 03801 Phone: 603-430-7595 Fax: 603-430-7746 | |
Rachel Duran, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 Lafayette Rd, Portsmouth, NH 03801 Phone: 603-430-7595 | |
Jenna H Sanborn, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Lafayette Rd, Portsmouth, NH 03801 Phone: 603-602-9070 Fax: 603-810-6881 | |
Keleon A D J Rockett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1390 Lafayette Rd, Portsmouth, NH 03801 Phone: 603-430-7595 | |
Mr. John Anthony Fratamico, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23 Osprey Drive, Portsmouth, NH 03801 Phone: 603-319-4649 Fax: 401-216-3352 | |
Janet Nadeau-leavitt, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 161 Corporate Dr, Portsmouth, NH 03801 Phone: 603-436-0562 Fax: 603-427-6155 | |
Maureen Mcpadden, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 117 Bow St Unit 114, Portsmouth, NH 03801 Phone: 603-303-3141 |